Longitudinal analysis of the depressive effects of intravenous amiodarone on depolarization and repolarization: a

Koichiro Yoshioka1, Mari Amino, Atsushi Matsuzaki

  • 1Department of Cardiology, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1193, Kanagawa, Japan. ko1@is.icc.u-tokai.ac.jp

Journal of Cardiology
|December 1, 2009
PubMed

Insights

Intravenous amiodarone (AMD) effectively reduced ventricular premature contractions by altering depolarization, even with prolonged QT intervals. Its antiarrhythmic effect relies on sodium channel blockade, not just repolarization changes.

Area of Science:

  • Cardiology
  • Clinical Electrophysiology
  • Pharmacology

Background:

  • Intravenous amiodarone (AMD) is used for treating ventricular arrhythmias.
  • AMD acts by blocking sodium (Na+), calcium (Ca2+), and IKr channels, and beta receptors.

Observation:

  • A patient on chronic dialysis received AMD for non-sustained ventricular tachycardia.
  • QT prolongation was observed 5 hours after AMD administration, with QTc reaching 716 ms.
  • Ventricular premature contractions (VPCs) decreased initially but increased after AMD withdrawal.

Findings:

  • AMD's Na+-channel blocking action altered depolarization, increasing filtered QRS duration and decreasing ventricular late potentials.
  • The antiarrhythmic effect on VPCs correlated with depolarization changes, not QT prolongation or AMD blood concentration.
  • AMD's efficacy in suppressing VPCs required its Na+-channel blocking action, irrespective of QT interval prolongation.

Implications:

  • The Na+-channel blocking property of AMD is crucial for its antiarrhythmic effect in ventricular tachycardia.
  • Understanding AMD's mechanism, particularly its impact on depolarization, is vital for managing cardiac arrhythmias.
  • This case highlights the complex electrophysiological effects of AMD, especially in patients with renal impairment.

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...